Generational Perspective in Multiple Sclerosis Care

2:00 MS as a previously untreatable disease and evolution of DMTs

5:49 Progress in treating MS

8:18 Anti-CD20 B-cell therapies in MS

10:48 CNS agents to treat MS

12:00 Evolution of risk assessment in MS

16:38 Escalation vs high efficacy approach in MS

22:40 Disease activity/progression in MS

26:59 Progression independent of relapse in MS

28:30 Patient reported outcomes and shared decision making

34:04 MS care in older patients